Sprouts Farmers Market closes $600 million revolving credit facility
LONDON - Convatec Group Plc, a global medical products and technologies company, has announced that its Annual General Meeting (AGM) is set to take place at 14:00 (UK time) on Thursday, May 22, 2025, at FGS Global, The Adelphi, in London. This follows the release of its 2024 Annual Report and Accounts and the Notice of Annual General Meeting to shareholders.
The documents, which detail the company’s performance for the year ended December 31, 2024, and information on the upcoming AGM, including proxy appointment instructions, have been submitted to the National Storage Mechanism in line with regulatory requirements. They are now available for public inspection on the Financial Conduct Authority’s National Storage Mechanism website.
Shareholders and interested parties can also access these documents on Convatec’s official website. The company, which specializes in products for Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, operates in approximately 90 countries and employs over 10,000 people. In 2024, Convatec reported revenues exceeding $2 billion and is listed on the London Stock Exchange (LON:LSEG) as part of the FTSE 100 Index under the ticker LSE:CTEC.
The AGM is a critical event for Convatec, as it provides an opportunity for shareholders to engage with the company’s management and vote on key decisions. The accompanying Annual Report offers insights into the company’s financial health and strategic direction.
The announcement of the AGM and the publication of the annual report are based on a press release statement from Convatec Group Plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.